Pfizer agrees to buy Seagen for USD 43 bn

Pfizer has agreed to pay USD 43 billion for biotech Seagen and its pioneering class of targeted cancer drugs, The Wall Street Journal reported.

Related Keywords

New York ,United States ,France ,French ,Albert Bourla ,Provention Bio ,Pfizer ,York Stock Exchange On ,Wall Street Journal ,New York Based Pfizer ,Executive Officer Albert Bourla ,New York Stock Exchange ,New York City News ,Revenue ,Said They ,Price ,Executives Said ,Eagen Which ,Pfizer Can ,Share Investing ,Sales ,Ased ,